3 FTSE 100 stocks that get Terry Smith’s seal of approval

Terry Smith remains one of the UK’s top large-cap fund managers, despite holding very few FTSE 100 (INDEXFTSE: UKX) stocks. Here are three exceptions.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The suspension of Neil Woodford’s flagship Equity Income Fund has served as a reminder that highly-regarded professional money managers can fall from grace in dramatic fashion. Nevertheless, one that many continue to have a lot of time for is Terry Smith, chief executive of Fundsmith.

Smith’s investment philosophy is simple: Buy quality companies, don’t overpay and then do nothing. It’s been a winning strategy for many years with his Fundsmith Equity Fund generating a 19.2% annualised return since its inception (compared to the 12% achieved by the MSCI World Index) as of the end of June. 

Importantly, this fund only contains between 20 and 30 holdings at any one time, few of which are London-listed. Here, however, are three that do make the grade. 

Smith-approved

It’s not surprising that drinks giant Diageo (LSE: DGE) holds a spot since it has a number of attributes Smith looks for when evaluating investment opportunities. The company generates consistently high returns on the money it invests and has such a grip on its industry that attempting to build a rival from scratch would be extremely hard to do.

By contrast to your average technology stock, Diageo also look fairly resilient to change. While younger generations may be drinking less these days, they seem happy to spend more when they do, hence the popularity of premium spirits the company specialises in. As such, it seems pretty likely revenue and profits will continue rising in the future. 

Unfortunately, Diageo’s defensive characteristics mean its stock rarely goes on sale. Should you want to add it to your own portfolio, you’ll need to pay almost 25 times forecast FY2020 earnings.

Unilever (LSE: ULVR) is another holding within the Fundsmith Equity Fund that ticks many of the same boxes as Diageo. The £131bn-cap specialises in producing the things Smith looks for — low ticket items that people buy again and again whatever the economic weather.

Consumers may reign in their spending on large, discretionary goods when the going gets tough, but they’re less likely to do so with jars of Marmite, bars of Dove soap or boxes of PG Tips. The power of its brands is also why Unilever continues to make heaps of cash even though shoppers are able to buy cheaper alternatives. 

Like Diageo, Unilever rarely enters ‘bargain’ territory. Is 22 times forecast earnings too expensive though?  For the quality on offer, I’d say not.

Perhaps the most interesting UK-based inclusion in the Fundsmith portfolio right now is fellow consumer goods company Reckitt Benckiser (LSE: RB). Shares in the owner of brands such as Durex and Dettol are currently almost 20% below the peak hit back in June 2017.

That follows a well-publicised cyber attack, manufacturing problems, investor concern over the pricey acquisition of Mead Johnson and criticism of the pay of (soon-to-depart) CEO Rakesh Kapoor.

More recently, the company has been embroiled in controversy surrounding the marketing of opioid treatment Suboxone Film by Indivior — a former subsidiary of that was spun-off in 2014. Last week, Reckitt wrote a cheque for $1.4bn to US authorities to put an end to this investigation. 

Despite all this, Smith doesn’t look like dropping the stock anytime soon. Indeed, with Reckitt currently trading at 19 times earnings (lower than its five-year average of 22.5), it’s possible he may consider adding to his position.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended Diageo. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Happy young plus size woman sitting at kitchen table and watching tv series on tablet computer
Investing Articles

Could Raspberry Pi shares hit £5 by 2030?

After a strong start out of the blocks this month, our writer asks whether Raspberry Pi shares could move further…

Read more »

Close-up of British bank notes
Investing Articles

Five 5%+ yielders I’d buy for an ISA today!

Our writer identifies a handful of FTSE 100 and FTSE 250 firms each yielding at least 5% he'd happily buy…

Read more »

Front view photo of a woman using digital tablet in London
Investing Articles

5 stocks with 5%+ yields I’d love to buy and hold in a Stocks and Shares ISA

Harvey Jones is keen to add these five FTSE 100 high-yielders to his Stocks and Shares ISA, ideally before they…

Read more »

A young Asian woman holding up her index finger
Investing Articles

I’d target £880 of passive income annually, spending £10K now on this FTSE 100 share

Our writer explains how he would add to his diversified portfolio happily by investing in this FTSE 100 passive income…

Read more »

Light trails from traffic moving down The Mound in central Edinburgh, Scotland during December
Investing Articles

3 reasons I think the Scottish Mortgage share price could keep rising

Christopher Ruane explains a trio of reasons he thinks the once-mighty Scottish Mortgage share price could be set to increase…

Read more »

Syringe and vial on blue background
Investing Articles

Is this forgotten FTSE share about to make investors rich all over again?

Not long ago, this FTSE share was all the rage before demand dropped off and things went south. Is it…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

I’d use these 5 Warren Buffett approaches to build wealth

Christopher Ruane outlines a handful of investing lessons from billionaire Warren Buffett that he thinks can help a small investor…

Read more »

US Stock

Nvidia stock: 3 things investors need to know as it surges towards $150

Nvidia is a stock that's had an extraordinary run in 2024. Edward Sheldon highlights some important things investors should know.

Read more »